SC notice to Centre, others on plea seeking data on Covid vaccine trials

The Supreme Court on Monday sought responses from the Centre and others on a plea seeking directions for disclosure of data regarding clinical trials of Covid-19 vaccines.

Covaxin has started trials on children; it would be for children who are two years or older
Press Trust of India New Delhi
1 min read Last Updated : Aug 09 2021 | 12:29 PM IST

The Supreme Court on Monday sought responses from the Centre and others on a plea seeking directions for disclosure of data regarding clinical trials of COVID-19 vaccines.

A bench of justices L Nageswara Rao and Hrishikesh Roy issued notice on the plea, and asked the Centre and others to respond to it within four weeks.

While hearing the plea, the bench referred to the problem of vaccine hesitancy in the country and asked advocate Prashant Bhushan, who was appearing for the petitioner, as to whether entertaining the petition would not create doubt in the minds of the citizens over vaccines.

While making it clear that neither it is an anti-vaccine petition nor the petitioner is seeking to stop Covid vaccination in the country, Bhushan said transparency on the issue was needed and disclosure of data would rather clear all the doubts.

The bench was hearing a plea seeking directions for disclosure of data on clinical trials of COVID-19 vaccines and also on post vaccination.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus Vaccineclinical trialsSupreme Court

First Published: Aug 09 2021 | 12:29 PM IST

Next Story